Company / Financials
60 DEGREES PHARMACEUTICALS, INC. Financials
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$607.6K
FY2025 · +139.6% YoY
Net Income
-$7.9M
FY2025 · -111.0% YoY
Profit Margin
-1308.0%
FY2025 · net income / revenue
ROE
-229.5%
FY2025 · return on equity
Total Assets
$5.4M
FY2025
Total Debt
-
FY2025
Equity
$3.5M
FY2025
ROA
-148.1%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -4.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$607.6K+139.6% YoYNet Income HistoryProfit after all expenses and taxes-$7.9M-111.0% YoYGross Profit HistoryRevenue minus cost of goods sold$222.8K+200.8% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$384.8K-18.9% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$9.7M-88.5% YoYSG&A Expense HistorySelling, general, and administrative expenses$5.0M+18.5% YoYR&D Expense HistoryResearch and development spending$5.0M+620.8% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense$0-100.0% YoYEPS (Basic) HistoryBasic earnings per share-$74.17-25.3% YoY